Abstract The bacterial genus Ralstonia (Gram-negative nonfermenters) is becoming more prevalent in cases of infection with three bacterial species, Ralstonia pickettii , Ralstonia insidiosa and Ralstonia mannitolilytica , making up all cases reported (in the literature) to date. These organisms are prevalent in many different types of water supplies (including hospital water supplies), being well adapted to survive in low-nutrient conditions. They have been shown to cause infections, sometimes serious, such as osteomyelitis and meningitis, in hospital settings. Seventy cases of R. pickettii, 13 cases of R. mannitolilytica and three cases of R. insidiosa infection have been identified from the literature. Insight is given into the types of infections that are caused by these bacteria, the underlying conditions that are associated with these infections and potential treatments.
Introduction
Gram-negative, non-fermenting bacteria are a growing concern in clinical environments, being one of the most common causes of nosocomial infections. The major opportunistic pathogens from this group comprise many bacterial species, including: Acinetobacter baumannii , Pseudomonas aeruginosa , Burkholderia cepacia and Stenotrophomonas maltophilia . These bacteria take advantage of underlying medical conditions and diseases to cause infection. Ralstonia spp. are amongst these non-fermenting Gramnegative bacteria that are emerging as opportunistic pathogens.
Ralstonia is a genus which includes former members of Burkholderia spp. (Burkholderia pickettii and Burkholderia solanacearum ). Ralstonia spp. are aerobic Gram-negative, non-fermentative rods that can be found in water and soil [1] . Ralstonia pickettii , the type species of the genus, was, until recently, regarded as the only member of the genus of clinical importance [2] . However, two novel Ralstonia spp. have been described recently that are considered to be of minor clinical importance, Ralstonia insidiosa [3] and Ralstonia mannitolilytica [2] . Investigation of instances of Ralstonia spp. infections in the literature showed many different types of infections (mostly with R. pickettii as the cause). This indicates that the genus may be a more extensive pathogen than was assumed previously, with the types of infections being more invasive and severe.
Bacteriology

Ralstonia pickettii
As stated, R. pickettii is the type species of the Ralstonia genus. The bacterium has been recovered from a wide variety of clinical specimens, including blood, urine and cerebrospinal fluid [4] . The bacteria has been isolated from numerous water sources, including municipal drinking water supplies [5] , bottled water [6] , dental water supplies [7] , hospital water supplies [8] , space shuttle water systems [9] , standard purified water [10] , laboratory-based high-purity water systems [11] and industrial ultra-pure/high-purity water [12] [13] [14] . R. pickettii has been identified in biofilm formation in plastic industrial water piping [13, 15] . R. pickettii is not thought of as a major pathogen and its virulence is thought to be low. It is, consequently, not routinely looked for in hospital analysis [2] . All reported instances of infection attributed to R. pickettii infection are described in Table 1 . water, soil, activated sludge [16] , laboratory purified water systems [3] , and industrial ultra-pure/high-purity water [16] and water distribution systems [18] . The bacteria has also been found in the lung sputum of cystic fibrosis suffers [2] . All reported instances of infection attributed to R. insidiosa infection are described in Table 2 .
Ralstonia mannitolilytica
Ralstonia mannitolilytica is also closely related to R. pickettii. R. mannitolilytica had previously been called "Pseudomonas thomasii" and R. pickettii biovar 3/"thomasii" [19] , and has been described in a number of hospital outbreaks [20] [21] [22] [23] .
Initial reports [24] described cases of bacteraemia and bacteriuria in 20 patients. These infections were linked to "P. thomasii"-contaminated parenteral fluids that had been prepared with deionised water contaminated with "P. thomasii". Pan et al. [23] reported an epidemic involving 24 patients that was caused by "P. thomasii"-contaminated saline solution that had been prepared by the hospital pharmacy. Pseudooutbreaks linked to R. mannitolilytica have also been described [25] . Reports have described it as causing meningitis and haemoperitoneum infection [26] , renal transplant infection [27] and bacteraemia [28] . R. mannitolilytica is the most prevalent species of the Ralstonia genus to be found in cystic fibrosis suffers [29] . All reported instances of infection attributed to R. mannitolilytica infection are described in Table 3 .
Identification of Ralstonia spp.
The three Ralstonia spp. are difficult to identify and differentiate from one another using routine hospital analysis [3, 28] . The three bacteria have very similar biochemical patterns to each other and to other bacterial species, such as the Burkholderia cepacia complex and Pseudomonas fluorescens [2, 3, 28] . The existing commercial biochemical identification systems on the market, e.g. API 20NE, RapID NE, Vitek etc., do not give the best identification, especially for some genera or species including Gram-negative nonfermenting rods [30] . Some identification methods may confound epidemiology, as Ralstonia spp. can be easily misidentified as Burkholderia cepacia complex and Pseudomonas fluorescens using routine methods as stated above. R. pickettii has been shown to give variable results using the standard biochemical test kits, e.g. API 20NE, and R. mannitolilytica and R. insidiosa have not been added to test panels [13] . The best way to tell the bacteria apart is through polymerase chain reaction (PCR) with speciesspecific PCR primers available for all three bacteria [17, 31] . 
Epidemiology
The population at risk from these bacteria comprises almost exclusively immunocompromised patients, for example, those with haematological malignancies (bacteraemia, septicaemia etc.), patients in intensive care, patients with indwelling devices such as central venous catheters, and neonates [32] [33] [34] [35] [36] [37] [38] . Examples of underlying conditions and Ralstonia spp. infection include: a 53-year-old man who had suffered a myocardial infarction and who contracted R. pickettii -related bacteraemia while recuperating in hospital; [30] a 32-yearold man who was suffering from hepatitis-C-related liver cirrhosis who contracted R. pickettii-related peritonitis [3] ; a 41-year-old man with underlying diabetes mellitus who developed R. pickettii-related pneumonia [39] ; a 7-year-old boy who received a cord blood transplant and then suffered an episode of R. pickettii -related bacteraemia [40] ; and a 71-yearold man with underlying chronic renal failure, diabetes mellitus, hypertension and alcoholic cirrhosis who developed R. pickettii -related osteomyelitis [41] . R. pickettii and R. mannitolilytica have also been associated in infections with permanent indwelling intravenous devices such as catheters [33, 42] .
Ralstonia spp. have been shown to be the causative agent of severe invasive infections, including osteomyelitis, septic arthritis, meningitis etc. [26, 41, 43] . Another example of severe infection due to R. pickettii is the case of a 38-yearold female who contracted both bacteraemia and meningitis [44] . In many of the more serious infections, the aetiology was unknown.
Reports have indicated that the occurrences of Ralstonia spp. infections (Tables 1, 2 and 3) are increasing. This rise could be associated with the increase in the patient population at risk (older populations, people surviving with serious illness for longer etc.), potentially as a result of the widespread use of antibiotics and the implementation of more invasive medical practices [2] .
Factors responsible for infection
Contaminated solutions
Many of the cases of infection with Ralstonia spp. are due to contaminated solutions, including water for injection, saline solutions made with purified water, respiratory solutions and sterile drug solutions [37, [45] [46] [47] . Contamination of these products generally occurs at the manufacturing stage. This contamination can occur through many different means, but one of the most important is due to the ability of Ralstonia spp. to pass through 0.2-μm filters that are used for the sterilisation of many medicinal products, such as saline solution [48, 49] . Another example of how solutions can become contaminated during the manufacturing stage was seen in 1983, when five infants became infected with R. pickettii that was associated with a contaminated respiratory therapy solution. R. pickettii contaminated the solution due to the bypassing of an 82°C holding tank during the manufacture of distilled water. This contaminated solution was then used for endotracheal suctioning and this allowed colonisation of the patients [45] .
Disinfectants R. pickettii has been shown to survive in different hospital disinfectants, including chlorhexidine. In 1983, six patients contracted R. pickettii-related septicaemia. The source of the contamination was traced back to the bidistilled water used to make up the 0.05 % aqueous solution of chlorhexidine. This was then used for skin antisepsis before the insertion of a venous catheter and lead to infection [50] . Contaminated chlorhexidine was also implicated in the recovery of R. pickettii from six paediatric patients in 1995 [51] . As before, the contaminated chlorhexidine was used for topical disinfection. R. pickettii has also been shown to survive ethacridine lactate (aromatic organic compound based on acridine) [52] .
Pseudo-outbreaks
Ralstonia spp. have been linked with pseudo-outbreaks, with seven such outbreaks being described in the literature (Tables 1 and 3 ). These pseudo-outbreaks have caused unnecessary treatments to be given to patients (e.g. wrong or unneeded antibiotics or the removal of indwelling devices) and are also a waste of valuable time and resources in hospital laboratories. Pseudo-outbreaks may be due to many different causes, including contaminated distilled water used in the bacterial testing procedures, phlebotomist error or contamination at the manufacturing stage of materials used in laboratory testing. Verschraegen et al. reported that R. pickettii was the cause of pseudobacteraemia in a surgical ward. This was the first such case reported in the literature [53] . The patients did not exhibit any signs of bacteraemia, even though the organism was isolated from blood samples. The contamination was traced to distilled water (used in the testing procedures) and a 0.5 % chlorhexidine solution (used to wipe the bench) prepared using the distilled water. Both of these were found in the hospital pharmacy. R. mannitolilytica has also been found to be the causative agent of pseudo-outbreaks in special-care baby wards [25] .
Treatment
The treatment and management of Ralstonia spp. infections is often challenging, as these pathogens are frequently resistant to numerous different types of antibiotics, including several β- lactams and most of the aminoglycosides. A major study into the antibiotic resistance of numerous strains of R. pickettii and R. insidiosa showed that both bacteria were highly resistant to the aminoglycoside gentamicin and the β-lactam antibiotic aztreonam, and variably resistant to the ticarcillin-clavulanic acid mix [54] . Two inducible β-lactamases in R. pickettii , bla OXA-60 and bla , are considered to be the reason for the high level of resistance to β-lactams [55, 56] . The presence of an aminoglycoside acetyl-transferase in R. pickettii genomes 12J and 12D also accounts for the widespread resistance to aminoglycosides (see Table 1 and reference [54] ). The study carried out by Ryan and Adley showed that most strains were susceptible to the carbapenem meropenem and all isolates were susceptible to the quinolones (ciprofloxacin and ofloxacin), the tetracyclines (tetracycline and minocycline), the cephalosporins (cefotaxime and ceftazidime), the folate pathway inhibitors (trimethoprim/sulfamethoxazole) and the extended-spectrum beta-lactam antibiotic of the ureidopenicillin class (piperacillin) [56] . Various different antibiotics have been used to treat infections of Ralstonia spp., including trimethoprim/sulfamethoxazole, ciprofloxacin, piperacillin, cefotaxime, ceftriaxone, imipenem, meropenem, levofloxacin and cefepime (Tables 1, 2 and 3) . What can be seen from these data is the failure of meropenem and ceftriaxone to treat infection in several instances and the need to use an alternative, which was mostly ciprofloxacin.
Conclusions
Ralstonia spp. are not recognized as major pathogens. However, in this paper, we have identified over 100 examples of Ralstonia spp. infections. These species have certain characteristics, such as resistance to disinfection practices and the ability to survive in water supplies, which allows them to cause many potentially harmful infections and death.
Methodology
All available publications discussing R. pickettii, R. insidiosa and R. mannitolilytica infections were searched for using the PubMed, Web of Knowledge, Science Direct and Google Scholar search databases from 1970 to 2013. The terms 'Ralstonia pickettii , 'Pseudomonas pickettii', 'Burkholderia pickettii', 'Ralstonia' and 'pickettii', 'Ralstonia insidiosa', 'insidiosa ', 'Ralstonia mannitolilytica ', 'mannitolilytica ', 'Pseudomonas thomasii' were all searched for and any references that discussed infection were set aside. These papers/ abstracts were then read and the required information extracted (year of outbreak, number/age/sex of patients, geographic location, underlying condition, condition caused by infection, susceptibility/resistance to antibiotics, antibiotics used to treat condition, clinical outcome). The reference sections of these publications were also checked for any infection-related references that may have been missed during the electronic searches.
